Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis.
Vennegoor A; Rispens T; Strijbis EM; Seewann A; Uitdehaag BM; Balk LJ; Barkhof F; Polman CH; Wolbink G; Killestein J; Multiple Sclerosis (Houndmills, Basingstoke, England), 2013, vol. 19, issue 5, p 593, ISSN 14770970. ISBN 14770970.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef